Protein Name |
Pfam ID |
Percentage of Identity (%) |
E value |
Receptor-interacting serine/threonine-protein kinase 2 (RIPK2)
|
|
44.444 (120/270) |
9.68E-56 |
Receptor-interacting protein 1 (RIPK1)
|
|
32.975 (92/279) |
7.82E-35 |
TGF-beta-activated kinase 1 (MAP3K7)
|
|
35.662 (97/272) |
6.08E-30 |
MLK-related kinase (MLTK)
|
|
30.337 (81/267) |
2.68E-25 |
Mixed lineage kinase 2 (MAP3K10)
|
|
30.241 (88/291) |
1.13E-22 |
Mixed lineage kinase 3 (MAP3K11)
|
|
30.420 (87/286) |
4.34E-21 |
Renal carcinoma antigen NY-REN-64 (IRAK-4)
|
|
33.663 (68/202) |
1.11E-20 |
Tyrosine-protein kinase Tec (PSCTK4)
|
|
28.679 (76/265) |
1.88E-20 |
Serine/threonine-protein kinase B-raf (BRAF)
|
|
30.418 (80/263) |
6.36E-20 |
Atrial natriuretic peptide receptor B (NPR2)
|
|
32.035 (74/231) |
8.99E-20 |
Tyrosine-protein kinase TXK (TXK)
|
|
28.114 (79/281) |
1.55E-19 |
Testis-specific kinase 2 (TESK2)
|
|
28.261 (78/276) |
1.80E-19 |
Tyrosine-protein kinase ZAP-70 (ZAP-70)
|
|
29.070 (75/258) |
2.12E-19 |
Hematopoietic cell kinase (HCK)
|
|
29.537 (83/281) |
3.01E-19 |
Ephrin type-B receptor 1 (EPHB1)
|
|
30.827 (82/266) |
3.68E-19 |
Ephrin type-A receptor 2 (EPHA2)
|
|
29.389 (77/262) |
9.73E-19 |
Ephrin type-A receptor 3 (EPHA3)
|
|
30.216 (84/278) |
1.21E-18 |
Ephrin type-A receptor 1 (EPHA1)
|
|
31.930 (91/285) |
2.02E-18 |
LCK tyrosine protein kinase (LCK)
|
|
28.470 (80/281) |
2.31E-18 |
Ephrin type-B receptor 4 (EPHB4)
|
|
29.699 (79/266) |
2.45E-18 |
Proto-oncogene c-RAF (c-RAF)
|
|
28.302 (75/265) |
2.46E-18 |
Focal adhesion kinase 1 (FAK)
|
|
27.953 (71/254) |
4.44E-18 |
Mixed lineage kinase 4 (MAP3K21)
|
|
29.329 (83/283) |
7.04E-18 |
Ephrin type-A receptor 4 (EPHA4)
|
|
31.179 (82/263) |
8.55E-18 |
Ephrin type-B receptor 2 (EPHB2)
|
|
30.566 (81/265) |
9.93E-18 |
Tropomyosin-related kinase A (TrkA)
|
|
27.737 (76/274) |
2.25E-17 |
Proto-oncogene c-Fes (FES)
|
|
26.415 (70/265) |
2.43E-17 |
Proto-oncogene c-Src (SRC)
|
|
29.961 (77/257) |
2.59E-17 |
Testis-specific kinase 1 (TESK1)
|
|
31.068 (64/206) |
4.37E-17 |
Tyrosine-protein kinase SYK (SYK)
|
|
31.628 (68/215) |
4.45E-17 |
Fyn tyrosine protein kinase (FYN)
|
|
28.521 (81/284) |
4.97E-17 |
Atrial natriuretic peptide receptor A (NPR1)
|
|
30.303 (70/231) |
5.42E-17 |
T-cell-specific kinase (ITK)
|
|
28.571 (82/287) |
5.95E-17 |
Insulin-like growth factor I receptor (IGF1R)
|
|
27.509 (74/269) |
6.13E-17 |
Proto-oncogene c-Met (MET)
|
|
27.879 (92/330) |
6.66E-17 |
Ephrin type-B receptor 3 (EPHB3)
|
|
30.075 (80/266) |
9.63E-17 |
Epidermal growth factor receptor (EGFR)
|
|
29.286 (82/280) |
1.03E-16 |
Inactive tyrosine-protein kinase 7 (PTK7)
|
|
27.706 (64/231) |
1.08E-16 |
Mitogen-activated protein kinase kinase kinase 12 (MAP3K12)
|
|
30.315 (77/254) |
1.13E-16 |
BDNF/NT-3 growth factors receptor (TrkB)
|
|
28.159 (78/277) |
1.19E-16 |
Insulin receptor-related protein (INSRR)
|
|
28.519 (77/270) |
1.47E-16 |
Janus kinase 3 (JAK-3)
|
|
26.715 (74/277) |
1.78E-16 |
Ephrin type-A receptor 5 (EPHA5)
|
|
30.268 (79/261) |
1.98E-16 |
Macrophage-stimulating protein receptor (RON)
|
|
29.965 (86/287) |
2.11E-16 |
Insulin receptor (INSR)
|
|
27.941 (76/272) |
2.51E-16 |
Focal adhesion kinase 2 (PTK2B)
|
|
28.295 (73/258) |
2.63E-16 |
Tyrosine-protein kinase FRK (FRK)
|
|
25.379 (67/264) |
2.74E-16 |
Yes tyrosine kinase (YES)
|
|
29.225 (83/284) |
3.85E-16 |
Tyrosine-protein kinase Lyn (JTK8)
|
|
28.462 (74/260) |
4.07E-16 |
Tyrosine-protein kinase Fgr (FGR)
|
|
28.906 (74/256) |
6.01E-16 |
Tyrosine-protein kinase ABL1 (ABL)
|
|
25.969 (67/258) |
7.55E-16 |
Tyrosine-protein kinase ABL2 (ABL2)
|
|
25.882 (66/255) |
7.69E-16 |
Ephrin type-A receptor 7 (EPHA7)
|
|
28.467 (78/274) |
8.67E-16 |
Tyrosine-protein kinase BMX (BMX)
|
|
27.203 (71/261) |
8.78E-16 |
Mitogen-activated protein kinase kinase kinase 13 (MAP3K13)
|
|
32.883 (73/222) |
9.37E-16 |
Mixed lineage kinase domain-like protein (MLKL)
|
|
29.596 (66/223) |
9.88E-16 |
LIM domain kinase-1 (LIMK-1)
|
|
25.723 (80/311) |
1.07E-15 |
Erbb2 tyrosine kinase receptor (HER2)
|
|
28.929 (81/280) |
1.75E-15 |
Ephrin type-A receptor 8 (EPHA8)
|
|
31.004 (71/229) |
2.58E-15 |
Tyrosine-protein kinase BRK (PTK6)
|
|
29.520 (80/271) |
7.04E-15 |
B lymphocyte kinase (BLK)
|
|
29.123 (83/285) |
1.35E-14 |
NT-3 growth factor receptor (TrkC)
|
|
26.948 (83/308) |
1.40E-14 |
Tyrosine-protein kinase UFO (AXL)
|
|
27.083 (78/288) |
1.55E-14 |
Proto-oncogene c-Ros (ROS1)
|
|
29.137 (81/278) |
1.59E-14 |
Tyrosine-protein kinase CSK (CSK)
|
|
27.969 (73/261) |
2.21E-14 |
Fibroblast growth factor receptor 2 (FGFR2)
|
|
25.000 (72/288) |
2.71E-14 |
Fibroblast growth factor receptor 4 (FGFR4)
|
|
23.843 (67/281) |
3.76E-14 |
Tyrosine-protein kinase Srms (SRMS)
|
|
28.364 (78/275) |
4.32E-14 |
Fibroblast growth factor receptor 3 (FGFR3)
|
|
24.910 (69/277) |
4.40E-14 |
Discoidin domain-containing receptor 2 (DDR2)
|
|
26.778 (64/239) |
4.89E-14 |
Ephrin type-A receptor 6 (EPHA6)
|
|
31.088 (60/193) |
6.11E-14 |
Megakaryocyte-associated tyrosine-protein kinase (MATK)
|
|
26.335 (74/281) |
9.08E-14 |
Proto-oncogene c-Fer (FER)
|
|
27.799 (72/259) |
1.21E-13 |
Erbb4 tyrosine kinase receptor (Erbb-4)
|
|
27.957 (78/279) |
1.74E-13 |
Serine/threonine-protein kinase A-Raf (ARAF)
|
|
25.271 (70/277) |
1.79E-13 |
Dual serine/threonine and tyrosine protein kinase (DSTYK)
|
|
32.447 (61/188) |
2.36E-13 |
LIM domain kinase-2 (LIMK-2)
|
|
27.570 (59/214) |
2.47E-13 |
TYRO3 tyrosine kinase receptor (TYRO3)
|
|
26.071 (73/280) |
3.28E-13 |
Proto-oncogene c-Ret (RET)
|
|
26.027 (76/292) |
3.43E-13 |
Tyrosine-protein kinase BTK (ATK)
|
|
25.912 (71/274) |
4.97E-13 |
Tyrosine-protein kinase Mer (MERTK)
|
|
27.309 (68/249) |
6.24E-13 |
Fibroblast growth factor receptor 1 (FGFR1)
|
|
24.595 (76/309) |
7.92E-13 |
TYK2 tyrosine kinase (TYK2)
|
|
26.619 (74/278) |
1.14E-12 |
Epithelial discoidin domain receptor 1 (DDR1)
|
|
27.347 (67/245) |
1.29E-12 |
Activated CDC42 kinase 1 (ACK-1)
|
|
28.302 (75/265) |
1.32E-12 |
Guanylyl cyclase C (GUCY2C)
|
|
26.840 (62/231) |
1.80E-12 |
Leukocyte receptor tyrosine kinase (LTK)
|
|
26.199 (71/271) |
3.25E-12 |
Janus kinase 1 (JAK-1)
|
|
24.286 (68/280) |
4.52E-12 |
Ankyrin repeat domain-containing protein 62 (ANKRD62)
|
|
29.646 (67/226) |
5.73E-12 |
Platelet-derived growth factor receptor alpha (PDGFRA)
|
|
27.895 (53/190) |
6.67E-12 |
Serine/threonine-protein kinase LMTK1 (AATK)
|
|
29.310 (85/290) |
8.70E-12 |
Janus kinase 2 (JAK-2)
|
|
25.939 (76/293) |
1.35E-11 |
Ankyrin and armadillo repeat-containing protein (ANKAR)
|
|
28.934 (57/197) |
1.59E-11 |
Muscle-specific kinase receptor (MUSK)
|
|
24.828 (72/290) |
2.93E-11 |
Krev interaction trapped protein 1 (KRIT1)
|
|
34.426 (42/122) |
4.70E-11 |
Activin receptor-like kinase 2 (ALK-2)
|
|
30.288 (63/208) |
5.38E-11 |
Vascular endothelial growth factor receptor 3 (FLT-4)
|
|
29.885 (52/174) |
6.91E-11 |
Platelet-derived growth factor receptor beta (PDGFRB)
|
|
29.487 (46/156) |
9.65E-11 |
TGF-beta receptor type II (TGFBR2)
|
|
24.497 (73/298) |
1.53E-10 |
Activin receptor-like kinase-1 (ACVRL1)
|
|
26.291 (56/213) |
1.95E-10 |
Neurotrophic tyrosine kinase ROR1 (ROR1)
|
|
25.540 (71/278) |
3.28E-10 |
Non-receptor tyrosine-protein kinase TNK1 (TNK1)
|
|
28.571 (76/266) |
3.44E-10 |
ALK tyrosine kinase receptor (ALK)
|
|
24.164 (65/269) |
6.42E-10 |
Vascular endothelial growth factor receptor 1 (FLT-1)
|
|
27.976 (47/168) |
1.30E-09 |
Ephrin type-A receptor 10 (EPHA10)
|
|
28.251 (63/223) |
1.80E-09 |
Vascular endothelial growth factor receptor 2 (KDR)
|
|
29.221 (45/154) |
2.93E-09 |
Angiopoietin 1 receptor (TEK)
|
|
25.000 (68/272) |
3.05E-09 |
DNA-binding protein RFXANK (RFXANK)
|
|
31.250 (40/128) |
3.74E-09 |
Bone morphogenetic protein receptor type-1A (BMPR1A)
|
|
26.267 (57/217) |
5.89E-09 |
Tie-1 tyrosine kinase receptor (TIE1)
|
|
25.090 (70/279) |
6.14E-09 |
Retinal guanylyl cyclase 2 (GUCY2F)
|
|
26.768 (53/198) |
1.33E-08 |
Kinase suppressor of Ras 2 (KSR2)
|
|
23.774 (63/265) |
2.57E-08 |
Bone morphogenetic protein receptor type-1B (BMPR1B)
|
|
26.636 (57/214) |
2.69E-08 |
Fms-like tyrosine kinase 3 (FLT-3)
|
|
27.215 (43/158) |
3.59E-08 |
Soluble guanylyl cyclase (GUCY2D)
|
|
26.667 (52/195) |
5.15E-08 |
Serine/threonine-protein kinase LMTK3 (LMTK3)
|
|
25.352 (72/284) |
5.56E-08 |
KN motif and ankyrin repeat domain-containing protein 4 (KANK4)
|
|
29.341 (49/167) |
8.36E-08 |
Tyrosine-protein kinase Kit (KIT)
|
|
28.824 (49/170) |
1.85E-07 |
Protein phosphatase 1 regulatory subunit 27 (PPP1R27)
|
|
31.818 (28/88) |
1.90E-07 |
Activin receptor type-1C (ACVR1C)
|
|
25.517 (74/290) |
2.16E-07 |
Tyrosine-protein kinase RYK (RYK)
|
|
25.439 (58/228) |
2.24E-07 |
Macrophage colony-stimulating factor 1 receptor (CSF1R)
|
|
26.752 (42/157) |
3.03E-07 |
CDK inhibitor 4C p18-INK4c (CDKN2C)
|
|
40.909 (36/88) |
4.18E-07 |
Serine/threonine-protein kinase LMTK2 (LMTK2)
|
|
23.774 (63/265) |
1.67E-06 |
Neurotrophic tyrosine kinase ROR2 (ROR2)
|
|
24.460 (68/278) |
1.68E-06 |
Erbb3 tyrosine kinase receptor (Erbb-3)
|
|
23.741 (66/278) |
3.57E-06 |
Click to Show/Hide the Information of Human Similarity Proteins |